Small study hints that revving up immune cells might help fight HIV
Scientists are tweaking a powerful cancer therapy in hopes it could fight HIV instead, by supercharging patients' own immune cells.
20 hours ago
0
4
HIV & AIDS news
HIV reveals more than 100 escape mutations against promising antibody therapies
Broadly neutralizing antibodies (bNAbs) are among the most promising new treatments for HIV, offering the potential to forego traditional daily doses of antiretroviral drugs. In one recent clinical study of bNAbs identified ...
May 12, 2026
0
8
Expanded TB screening in HIV wards fails to speed treatment, clinical trial shows
A clinical trial conducted in Tanzania and Mozambique and published in The Lancet Infectious Diseases concludes that expanding the use of molecular diagnostic tests on urine and stool samples, in addition to sputum, to detect ...
May 8, 2026
0
3
How HIV hijacks a cellular 'gateway' to infect resting immune cells
Researchers from Queen Mary University of London have uncovered a previously unknown mechanism by which HIV-1 can infect resting immune cells. The discovery challenges a decades-old assumption in HIV biology, and opens new ...
May 6, 2026
0
5
Marker of biological aging linked to cognitive symptoms of depression
Blood tests measuring the aging of certain white blood cells can predict cognitive and mood-related symptoms of depression, rather than physical symptoms. These findings, published in The Journals of Gerontology, Series A: ...
May 4, 2026
0
7
FDA approves once-daily Idvynso tablet for treating HIV
The U.S. Food and Drug Administration has approved Merck's Idvynso (doravirine/islatravir), a new, once-daily, two-drug single tablet for the treatment of HIV-1 infection in adults to replace the current antiretroviral regimen ...
May 1, 2026
0
22
The Bangui operation: A story of blood, science and biomedical exploitation
In the early 1990s, a secret HIV vaccine research project was carried out in the Central African Republic. The project didn't yield results and was hidden for many years. Today it sheds light on debates over clinical trials, ...
May 1, 2026
0
4
New HIV vaccine design trains immune system to hit shared viral target across variants
Researchers at Karolinska Institutet, in collaboration with colleagues at The Scripps Research Institute and Emory University, have developed a new vaccine strategy that has generated antibodies capable of neutralizing highly ...
Apr 29, 2026
0
16
HIV disrupts lung 'clock,' raising COPD and emphysema risk
People living with HIV face a greater risk of developing lung diseases at a much younger age, even if they have never smoked. FIU researchers have now uncovered a previously unknown mechanism that helps explain how HIV causes ...
Apr 25, 2026
0
7
Long-acting HIV shots appeal to many but uptake remains low
When it comes to HIV medication, many patients think they'd prefer an occasional injection over a daily pill, but uptake remains an issue, according to a Rutgers Health-led survey. When researchers surveyed 801 people living ...
Apr 23, 2026
0
5
